2017
DOI: 10.1016/s0016-5085(17)31131-9
|View full text |Cite
|
Sign up to set email alerts
|

A Multicenter, Open-Label, Randomized Trial of Vonoprazan Versus PPI Based 7-Day Triple Therapy for the First-Line Treatment of Helicobacter Pylori Infection

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles